Covid: China's Sinovac vaccine gets WHO emergency approval
It is the second Chinese vaccine to get the green light from the global health body.
www.bbc.com
- Thread starter beeza
- Start date
Sinovac approved by WHO
- Status
www.bbc.com
Brazil Covid: Deaths plunge after town's adults vaccinated
https://www.bbc.com/news/world-latin-america-57309538
A Brazilian town has seen a 95% drop in Covid-19 deaths after almost all adults were vaccinated as part of an experiment, researchers say.
Serrana, with 45,000 inhabitants, saw cases plunge after a mass vaccination with the Chinese-developed CoronaVac.
The team said those who had not been vaccinated were also protected by the reduction in the virus's circulation.
The findings suggest the pandemic can be controlled after 75% of people are fully dosed.
Brazil has been hit hard by the pandemic, with nearly 463,000 deaths.
The country is struggling with a slow vaccination campaign due to insufficient jabs, while the average of daily deaths and cases remains high amid a lack of co-ordinated measures to curb infections.
The experiment in Serrana, in the south-eastern São Paulo state, was carried out between February and April by Instituto Butantan, which produces the CoronaVac vaccine developed by China's Sinovac Biotech.
The city was divided into four areas to help determine the threshold for containing the virus. The team said this was achieved after three areas, or about 75% of the population over the age of 18, had been given both doses.
When 95% of adults were fully vaccinated, they said the results showed that:
Deaths fell by 95%
Hospitalisations fell by 86%
Symptomatic cases fell by 80%
Ricardo Palacios, research director at Butantan, said the key figure was the 75%.
"The most important result is that we can control the pandemic without having to vaccinate the whole population," he said.
Mr Palacios also said there was a decline in the number of cases among children and teenagers, who had not been vaccinated. This could indicate that there was no need to vaccinate children for schools to reopen, he said.
According to Mr Palacios, the vaccine was also effective against the variant originally known as P.1, and now called Gamma, that was first identified in the northern city of Manaus and has been blamed for a surge in cases across the country.
Serrana, some 315km (195 miles) from São Paulo, is surrounded by cities that are grappling with a spike in infections. A lockdown is in place in Ribeirão Preto, located 24km away with a population of 710,000.
The results of the experiment could give a boost to the CoronaVac, which is being used by dozens of developing countries. There was some controversy about the vaccine this year, after clinical trials in Brazil, Indonesia and Turkey put its efficacy in a range of 50% to 90%.
The CoronaVac is an inactivated vaccine, and works by using killed viral particles to expose the body's immune system to the virus without risking a serious disease response.
The experiment in Serrana was the first of its kind in the world, its authors said. There were no reports of severe side effects from the vaccine and no Covid-related deaths among those who had been vaccinated 14 days after the second shot was applied, the results showed.
A similar study is being carried out in another Brazilian city, Botucatu, which has a population of 148,000. Researchers are using the Oxford/AstraZeneca vaccine, produced locally by the Fiocruz institute.
Brazil has the second-highest Covid death toll in the world after the US, and the third-highest number of cases, at more than 16.5 million. The Brazilian Senate is holding an inquiry into President Jair Bolsonaro's handling of the pandemic and the slow roll-out of the vaccine programme.
https://www.bbc.com/news/world-latin-america-57309538
A Brazilian town has seen a 95% drop in Covid-19 deaths after almost all adults were vaccinated as part of an experiment, researchers say.
Serrana, with 45,000 inhabitants, saw cases plunge after a mass vaccination with the Chinese-developed CoronaVac.
The team said those who had not been vaccinated were also protected by the reduction in the virus's circulation.
The findings suggest the pandemic can be controlled after 75% of people are fully dosed.
Brazil has been hit hard by the pandemic, with nearly 463,000 deaths.
The country is struggling with a slow vaccination campaign due to insufficient jabs, while the average of daily deaths and cases remains high amid a lack of co-ordinated measures to curb infections.
The experiment in Serrana, in the south-eastern São Paulo state, was carried out between February and April by Instituto Butantan, which produces the CoronaVac vaccine developed by China's Sinovac Biotech.
The city was divided into four areas to help determine the threshold for containing the virus. The team said this was achieved after three areas, or about 75% of the population over the age of 18, had been given both doses.
When 95% of adults were fully vaccinated, they said the results showed that:
Deaths fell by 95%
Hospitalisations fell by 86%
Symptomatic cases fell by 80%
Ricardo Palacios, research director at Butantan, said the key figure was the 75%.
"The most important result is that we can control the pandemic without having to vaccinate the whole population," he said.
Mr Palacios also said there was a decline in the number of cases among children and teenagers, who had not been vaccinated. This could indicate that there was no need to vaccinate children for schools to reopen, he said.
According to Mr Palacios, the vaccine was also effective against the variant originally known as P.1, and now called Gamma, that was first identified in the northern city of Manaus and has been blamed for a surge in cases across the country.
Serrana, some 315km (195 miles) from São Paulo, is surrounded by cities that are grappling with a spike in infections. A lockdown is in place in Ribeirão Preto, located 24km away with a population of 710,000.
The results of the experiment could give a boost to the CoronaVac, which is being used by dozens of developing countries. There was some controversy about the vaccine this year, after clinical trials in Brazil, Indonesia and Turkey put its efficacy in a range of 50% to 90%.
The CoronaVac is an inactivated vaccine, and works by using killed viral particles to expose the body's immune system to the virus without risking a serious disease response.
The experiment in Serrana was the first of its kind in the world, its authors said. There were no reports of severe side effects from the vaccine and no Covid-related deaths among those who had been vaccinated 14 days after the second shot was applied, the results showed.
A similar study is being carried out in another Brazilian city, Botucatu, which has a population of 148,000. Researchers are using the Oxford/AstraZeneca vaccine, produced locally by the Fiocruz institute.
Brazil has the second-highest Covid death toll in the world after the US, and the third-highest number of cases, at more than 16.5 million. The Brazilian Senate is holding an inquiry into President Jair Bolsonaro's handling of the pandemic and the slow roll-out of the vaccine programme.
Just as important - the studies are broader..... more conclusive.....
Better feedback from the larger samples
Better feedback from the larger samples
But CV19 has now morped into a Delta Force version. Sinovac work on that one ? That Indian super strain has now been politically correctly namded "Delta" and here we go again:
Despite this success, Britain is now coping with a rise in Covid cases. The main cause appears to be the highly infectious virus variant known as Delta, which was first detected in India. Britain’s recent moves to reopen society also probably play a role. |
The increase is a reminder that progress against the pandemic — even extreme progress — does not equal ultimate victory. Britain’s experience also suggests that cases may soon rise in the U.S. “What we’re seeing in U.K. is very likely to show up in other Western countries soon,” The Financial Times’s John Burn-Murdoch wrote. |
Will deaths rise? |
Fortunately, the current surge is almost certain to cause less death than previous outbreaks, because most people vulnerable to serious illness have already been vaccinated. About 90 percent of Britons 65 and older have received both shots. And the vaccines continue to look effective against the Delta variant, researchers say. |
For now, deaths have barely risen, and it’s possible that they will not rise much; the Covid death rate for people under 40 has been very low. But it is too soon to know. Covid death trends typically trail case trends by a few weeks. If the Delta variant ends up being significantly more severe, it could cause an increase in deaths. |
“There are reasons to be hopeful — we’re not seeing a big trend in hospital admissions — but it’s early days,” James Naismith, who runs the Rosalind Franklin Institute, a research center, told The Times. “If we don’t see anything by June 14, we can exhale.” |
British officials are debating whether to stick to their earlier plan to remove all activity restrictions on June 21 or push back that date. |
- Status